Print health ad spending rises in January; Novo program fights urban diabetes;

> Print health ad spending in the U.S. totaled $45 million in January, a 7% year-on-year increase. Report

> Novo Nordisk ($NVO) has launched "Cities Changing Diabetes," a partnership program to fight urban diabetes. Release

> BioAlliance Pharma has fired Oravig marketing partner Vestiq Pharmaceutical and has updated its marketing partnership for Loramyc. Release

> Stallergenes has won FDA approval for Oralair, an immunotherapy allergy tablet that will be marketed by Greer. Release

> With Sanofi Oncology's ($SNY) "Strollin' Colon" display, onlookers can walk through a giant inflatable colon and learn about the colorectal cancer screening process. More

> Johnson & Johnson Middle East ($JNJ) has teamed up with Impact BBDO Dubai to create a grandparents-only app and digital photo frame that receives and displays photos of grandchildren. More

> Specialty pharma Clinigen Group has acquired Savene, an oncology support therapy, from SpePharm AG. Release

And Finally... What is a patent troll? Congress, courts try to find out. Report